JAMES DAVID RODGERS,ARGYRIOS GEORGIOS ARVANITIS,THOMAS P. MADUSKUIE, JR.,STACEY SHEPARD,HAISHENG WANG,NIKOO FALAHATPISHEH,MARIA RAFALSKI,LOUIS STORACE,JORDAN S. FRIDMAN,KRISHNA VADDI
申请号:
PT06839328
公开号:
PT1966202E
申请日:
2006.12.12
申请国别(地区):
PT
年份:
2012
代理人:
摘要:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines (I) and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.